BIONURE  

Orphan ophtalmology

Sector

Drug discovery

Stage

Late pre-clinical stage

Funding needed

960 000 €

Country

Spain

Focused on rare ophtalmological diseases

With a candidate with dual remyelination and neuroprotective activity

Intravenous, acute and recurrent treatment

BIONURE has been successfully funded with Capital Cell
This project has already been reviewed by the BioExpert Network; the outcome was POSITIVE.
If you want to have more information or you want to review the project, you have to login or register

RELATED PROJECTS

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar